Currently, there are 31.32M common shares owned by the public and among those 29.80M shares have been available to trade.
The company’s stock has a 5-day price change of -24.57% and -31.75% over the past three months. DRIO shares are trading -11.72% year to date (YTD), with the 12-month market performance down to -66.31% lower. It has a 12-month low price of $0.63 and touched a high of $2.60 over the same period. DRIO has an average intraday trading volume of 484.39K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -13.43%, -12.89%, and -35.77% respectively.
Institutional ownership of DarioHealth Corp (NASDAQ: DRIO) shares accounts for 21.01% of the company’s 31.32M shares outstanding.
It has a market capitalization of $26.64M and a beta (3y monthly) value of 1.41. The earnings-per-share (ttm) stands at -$0.97. Price movements for the stock have been influenced by the stock’s volatility, which stands at 35.06% over the week and 23.53% over the month.
Earnings per share for the fiscal year are expected to increase by 41.97%, and 12.80% over the next financial year.
Looking at the support for the DRIO, a number of firms have released research notes about the stock. Alliance Global Partners stated their Buy rating for the stock in a research note on May 13, 2022, with the firm’s price target at $8.75. Cowen coverage for the DarioHealth Corp (DRIO) stock in a research note released on April 22, 2021 offered a Outperform rating with a price target of $31. Stifel was of a view on March 23, 2021 that the stock is Buy, while Cantor Fitzgerald gave the stock Overweight rating on February 25, 2021, issuing a price target of $35. Alliance Global Partners on their part issued Neutral rating on February 01, 2021.
